ArticleDiscover oncology2025

Pyrotinib monotherapy for advanced HER2-positive esophageal adenocarcinoma with trastuzumab resistance and chemotherapy intolerance: a case report and literature review.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.